Viewing StudyNCT00497224



Ignite Creation Date: 2024-05-05 @ 5:36 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00497224
Status: COMPLETED
Last Update Posted: 2019-05-30
First Post: 2007-07-04

Brief Title: Phase II Trial of Erlotinib in Advanced Pancreatic Cancer
Sponsor: University Health Network Toronto
Organization: University Health Network Toronto

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-11
Start Date Type: None
Primary Completion Date: 2008-12
Primary Completion Date Type: ACTUAL
Completion Date: 2013-06
Completion Date Type: ACTUAL
First Submit Date: 2007-07-04
First Submit QC Date: July 5 2007
Study First Post Date: 2007-07-06
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-05-27
Last Update Post Date: 2019-05-30
Last Update Post Date Type: ACTUAL